Search Results - "KIKUNO, N"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity by KIKUNO, N, SHIINA, H, DAHIYA, R, URAKAMI, S, KAWAMOTO, K, HIRATA, H, TANAKA, Y, PLACE, R. F, POOKOT, D, MAJID, S, IGAWA, M

    Published in Oncogene (06-12-2007)
    “…Astrocyte-elevated gene-1 (AEG-1) has been reported to be upregulated in several malignancies and play a critical role in Ha-ras-mediated oncogenesis through…”
    Get full text
    Journal Article
  3. 3

    Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials by Regan, M.M., O'Donnell, E.K., Kelly, W.K., Halabi, S., Berry, W., Urakami, S., Kikuno, N., Oh, W.K.

    Published in Annals of oncology (01-02-2010)
    “…Docetaxel is associated with prolonged survival in castration-resistant prostate cancer (CRPC). Platinum compounds have modest but distinct single-agent…”
    Get full text
    Journal Article
  4. 4

    RETRACTED ARTICLE: Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity by Kikuno, N, Shiina, H, Urakami, S, Kawamoto, K, Hirata, H, Tanaka, Y, Place, R F, Pookot, D, Majid, S, Igawa, M, Dahiya, R

    Published in Oncogene (06-12-2007)
    “…Astrocyte-elevated gene-1 (AEG-1) has been reported to be upregulated in several malignancies and play a critical role in Ha-ras-mediated oncogenesis through…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis by Kishi, Hirofumi, Igawa, Mikio, Kikuno, Nobuyuki, Yoshino, Tateki, Urakami, Shinji, Shiina, Hiroaki

    Published in The Journal of urology (01-05-2004)
    “…Although survivin expression has been reported in prostate cancer, the clinical significance of survivin expression remains unclear. To clarify the clinical…”
    Get more information
    Journal Article
  9. 9

    Brain Metastasis in a Patient with a Sarcomatoid Variant RCC with Well-controlled Extracerebral Metastases by Temsirolimus by KIKUNO, Nobuyuki, KENNOKI, Takafumi, FUKUDA, Hironori, MATSUMOTO, Yuichi, TSUNOYAMA, Kuniko, BAN, Shinichi, SATOH, Hideaki, RYOJI, Osamu

    Published in Anticancer research (01-08-2012)
    “…The sarcomatoid variant of metastatic renal cell carcinoma (RCC) has often an aggressive course and a poor prognosis, particularly when accompanied with brain…”
    Get full text
    Journal Article
  10. 10

    Combination chemotherapy with paclitaxel, estramustine and carboplatin for hormone refractory prostate cancer by Urakami, Shinji, Igawa, Mikio, Kikuno, Nobuyuki, Yoshino, Tateki, Kishi, Hirofumi, Shigeno, Kazushi, Shiina, Hiroaki

    Published in The Journal of urology (01-12-2002)
    “…The activity of estramustine phosphate is synergistic with paclitaxel against hormone refractory prostate cancer. Moreover, the single agent activity of…”
    Get more information
    Journal Article
  11. 11

    Gain curves of a microchannel plate ion detector for measurement of end-loss ions in the tandem mirror by GOTO, T, ISHII, K, YATSU, K, TAMANO, T, TAKAHASHI, T, ABE, A, KATSUKI, Y, KIKUNO, N, GOI, Y, ONO, Y, ISHIBASHI, N, NAKASHIMA, Y

    Published in Japanese Journal of Applied Physics (01-06-1996)
    “…A microchannel plate (MCP) is used as an ion detector in the end-loss energy component analyzer, which has been developed in order to measure velocity…”
    Get full text
    Journal Article
  12. 12

    Docetaxel-based chemotherapy as second-line treatment for paclitaxel-based chemotherapy-resistant hormone-refractory prostate cancer: A pilot study by Urakami, Shinji, Yoshino, Tateki, Kikuno, Nobuyuki, Imai, Shin, Honda, Satoshi, Yoneda, Tatuaki, Kishi, Hirofumi, Shigeno, Kazushi, Shiina, Hiroaki, Igawa, Mikio

    Published in Urology (Ridgewood, N.J.) (01-03-2005)
    “…To examine docetaxel (DTX)-based chemotherapy in paclitaxel (PTX)-based chemotherapy-resistant hormone-refractory prostate cancer (HRPC) to investigate the…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cells by KIKUNO, Nobuyuki, MORIYAMA-GONDA, Nobuko, IGAWA, Mikio, YOSHINO, Tateki, YONEDA, Tatsuaki, URAKAMI, Shinji, TERASHIMA, Masaharu, YOSHIDA, Manabu, KISHI, Hirofumi, SHIGENO, Kazushi, SHIINA, Hiroaki

    Published in Cancer research (Chicago, Ill.) (15-10-2004)
    “…Recently, survival benefit by chemotherapy using paclitaxel (PTX) and the induction of thymidine phosphorylase (TP) by PTX have been reported in several solid…”
    Get full text
    Journal Article
  16. 16

    The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer by Kikuno, Nobuyuki, Yoshino, Tateki, Urakami, Shinji, Shigeno, Kazushi, Kishi, Hirofumi, Hata, Kohkichi, Shiina, Hiroaki, Igawa, Mikio

    Published in Anticancer research (01-03-2003)
    “…Thymidine phosphorylase (TP) is associated with tumor angiogenesis. The aim of this study was to investigate the role of TP mRNA expression in the angiogenesis…”
    Get more information
    Journal Article
  17. 17

    Traumatic rhabdomyolysis resulting from continuous compression in the exaggerated lithotomy position for radical perineal prostatectomy by KIKUNO, NOBUYUKI, URAKAMI, SHINJI, SHIGENO, KAZUSHI, KISHI, HIROFUMI, SHIINA, HIROAKI, IGAWA, MIKIO

    Published in International journal of urology (01-09-2002)
    “…This report demonstrates a case of rhabdomyolysis as a result of the exaggerated lithotomy position during radical perineal prostatectomy. The pathogenesis,…”
    Get full text
    Journal Article
  18. 18

    End-loss ion analysis using an end-loss energy component analyzer in the tandem mirror by ISHII, K, GOTO, T, TAMANO, T, GOI, Y, KATSUKI, Y, KIKUNO, N, NAGASAKI, M, ISHIBASHI, N, ONO, Y, KATANUMA, I, YATSU, K

    “…In open systems, velocity distribution functions of end-loss ions provide information not only about ion axial confinement but also about the noticeable…”
    Get full text
    Journal Article
  19. 19

    Direct measurements of ion distribution function in loss cones and plasma potential in the tandem mirror (oral) by Ishii, Kameo, Takahashi, Toshiki, Abe, Akira, Kikuno, Nagayoshi, Goto, Tetsuya, ~:atsuki, Yuzo, Katanuma, Isao, Itakura, Akiyosi, Ichimura, Makoto, Kiwamoto, Yosuhito, Yatsu, Kiyoshi, Tamano, Teruo

    Published in Fusion engineering and design (01-03-1997)
    “…In order to measure velocity distribution functions of end-loss ions in the tandem mirror, a diagnostic device named ELECA (End-Loss Energy Component Analyzer)…”
    Get full text
    Journal Article
  20. 20